Nenad lisuride transdermal patch regulatory update

EMEA's CHMP issued a negative opinion on an MAA from Axxonis for Nenad lisuride transdermal patch to treat restless legs syndrome (RLS). CHMP said there was not enough evidence to demonstrate Nenad's ...